We are live on ! Find out more
NNVC icon

NanoViricides
NNVC

43 hedge funds and large institutions have $3.51M invested in NanoViricides in 2025 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 12 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 3

267% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 3

72% more capital invested

Capital invested by funds: $2.04M → $3.51M (+$1.47M)

23% more funds holding

Funds holding: 35 → 43 (+8)

5.51% more ownership

Funds ownership: 8.89% → 14.4% (+5.5%)

Holders
43
Holders Change
+8
Holders Change %
+22.86%
% of All Funds
0.52%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
12
Reduced
3
Closed
3
Calls
$54K
Puts
–
Net Calls
+$54K
Net Calls Change
-$9K

Top Buyers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
+$1.92M
2
Jane Street
Jane Street
New York
+$174K
3
MFS
Miller Financial Services
Michigan
+$101K
4
Citadel Advisors
Citadel Advisors
Florida
+$88.7K
5
TSS
Two Sigma Securities
New York
+$24.2K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$52.1K
2
Citigroup
Citigroup
New York
-$7.39K
3
ASN
Advisory Services Network
Georgia
-$4.29K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$486
5
SS
SBI Securities
Japan
-$429

NNVC Hedge Fund Activity: Q4 2025 in Review

43 of the 8,270 institutional investors tracked by Wall St. Rank reported a position in NanoViricides (NNVC) for Q4 2025, worth a combined $3.51M — up 72% from $2.04M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new NNVC positions and 3 closed out — a net gain of 8 holders — while 12 added to existing stakes and 3 trimmed.

The largest buyer was Armistice Capital, opening a new position worth an estimated $1.92M. The largest seller was Renaissance Technologies, cutting an estimated $52.1K.

  • 43 institutional investors held NanoViricides (NNVC) as of Q4 2025, up from 35 in Q3 2025.
  • Funds reported $3.51M of NanoViricides stock for Q4 2025, up 72% quarter-over-quarter.
  • 11 funds opened new NanoViricides positions in Q4 2025 and 3 closed out, a net change of +8 holders.
  • The largest NanoViricides buyer in Q4 2025 was Armistice Capital, an estimated $1.92M added.
  • The largest NanoViricides seller in Q4 2025 was Renaissance Technologies, an estimated $52.1K sold.

Based on aggregated 13F filings for Q4 2025.